Evogene - Wondering if anyone has done any due diligence on this Israel-based plant genomics company. Looks pretty interesting to me, and they have multiple field trials and collaborations ongoing. Below is the blurb I received today, and I just started looking at the prospectus.
Name of issuer
Evogene Ltd.
Industry
Consumer Products
Security type
Ordinary Shares
Expected size of offering
5,000,000 Shares
Expected price range
Our ordinary shares are listed on the Tel Aviv Stock Exchange, or TASE, under the symbol “EVGN.” On November 5, 2013, the last reported sale price of our ordinary shares on the TASE was NIS 60.62, or $17.16, per share (based on the exchange rate reported by the Bank of Israel on such date, which was NIS 3.532 = $1.00), giving prospective effect to the 1-for-2 reverse share split of our ordinary shares, which is to be effected prior to the effectiveness of the registration statement. (See Red Herring)
Offering type
Initial Public Offering
Distribution by
The Issuer
Expected pricing date
11/20/2013
Indication of Interest Period
11/12/2013 to 11/19/2013 by (4pm EST)
